Elarekibep + Placebo
Phase 1Terminated 0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Healthy Subjects (Indication: Asthma)
Conditions
Healthy Subjects (Indication: Asthma)
Trial Timeline
Apr 11, 2023 → Jul 8, 2023
NCT ID
NCT05794672About Elarekibep + Placebo
Elarekibep + Placebo is a phase 1 stage product being developed by AstraZeneca for Healthy Subjects (Indication: Asthma). The current trial status is terminated. This product is registered under clinical trial identifier NCT05794672. Target conditions include Healthy Subjects (Indication: Asthma).
What happened to similar drugs?
20 of 20 similar drugs in Healthy Subjects (Indication: Asthma) were approved
Approved (20) Terminated (1) Active (0)
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05794672 | Phase 1 | Terminated |
Competing Products
20 competing products in Healthy Subjects (Indication: Asthma)
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Use of Wearable Digital Sensors After mRNA Vaccination in Adults | Moderna | Preclinical | 0 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| mRNA-6231 | Moderna | Phase 1 | 0 |
| Letrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Isotretinoin | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Fexofenadine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sertraline | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Nizatidine + Axid | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Anastrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-1273.712 | Moderna | Approved | 0 |
| Risperidone | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Metformin + Glucophage | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| Divalproex Sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sirolimus | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Glimepiride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Ziprasidone Hydrochloride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Naproxen sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |